Coty Inc.: Form 10-Q for the period ended Dec 31, 2014
Filed with the SEC on Feb 5, 2015 and accepted by EDGAR at Feb 5, 2015, 16:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $1.26bn | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months2014-07-01 to 2014-12-31 | $2.44bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months2014-10-01 to 2014-12-31 | $508.9m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2014-07-01 to 2014-12-31 | $991.1m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $750.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2014-07-01 to 2014-12-31 | $1.45bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2014-10-01 to 2014-12-31 | $536.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2014-07-01 to 2014-12-31 | $1.06bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-10-01 to 2014-12-31 | $183.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2014-07-01 to 2014-12-31 | $303.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-10-01 to 2014-12-31 | $17.4m | us-gaap:InterestExpense |
| Interest expense | 6 months2014-07-01 to 2014-12-31 | $36.8m | us-gaap:InterestExpense |
| Income tax | 3 months2014-10-01 to 2014-12-31 | $29.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2014-07-01 to 2014-12-31 | $24.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $125.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2014-07-01 to 2014-12-31 | $136.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2014-07-01 to 2014-12-31 | $0.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2014-07-01 to 2014-12-31 | $0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-10-01 to 2014-12-31 | 362,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2014-07-01 to 2014-12-31 | 363,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2014-07-01 to 2014-12-31 | $355.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2014-07-01 to 2014-12-31 | $103.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 6 months2014-07-01 to 2014-12-31 | $149.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $1.20bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $2.72bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $6.39bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $2.23bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $5.64bn | us-gaap:Liabilities |
| Long-term debt | At period end2014-12-31 | $2.71bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-12-31 | $691.6m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2014-12-31 | $28.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-12-31 | $641.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-15-000002. Last ingested by Listed: Nov 11, 2026, 03:30 ET. Listed shows no prices and gives no investment advice.